Selective Anticancer Effects of a P-I Metalloproteinase from Bothrops Moojeni Snake Venom (BthMP) on Lung Cancer Cells
Pharmaceuticals · 06.03.2026 · 19 (3) · 428
DOI: 10.3390/ph19030428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 06.03.2026. Verfasst von Vinícius Queiroz Oliveira und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute Multidisciplinary in Health, Universidade Federal da Bahia (UFBA), Vitória da Conquista 45029-094, BA, Brazil. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Fundação de Amparo à Pesquisa do Estado da Bahia.
Abstract (Originalsprache)
Background
Lung cancer remains a leading cause of mortality, mainly due to aggressive metastasis and therapeutic resistance. Snake venom metalloproteinases (svMPs), particularly the P-I class, are promising sources for novel antitumor agents.
Objectives
This study investigated the impacts of BthMP, a P-I svMPs from Bothrops moojeni venom, on human lung carcinoma (A549) cells in comparison to non-cancerous human bronchial epithelial cells (BEAS-2B). Methods and Results: BthMP demonstrated potent and selective anti-cancer activity. It significantly inhibited key metastatic processes in A549 cells, including adhesion, migration, and invasion, while suppressing long-term proliferation, as shown by reduced colony formation and increased lactate dehydrogenase (LDH) release. Mechanistically, BthMP induced a massive increase in intracellular reactive oxygen species (ROS) by over 2000% and elevated nitric oxide (NO) by 35% in A549 cells, driving a state of lethal oxidative stress. Crucially, these cytotoxic and anti-metastatic effects were minimal in BEAS-2B cells; BthMP even suppressed basal ROS and NO levels in this non-cancerous line. The anti-migratory effects of BthMP were completely dependent on its zinc-based catalytic activity, as they were abolished by pretreatment with ethylenediaminetetraacetic acid. By simultaneously disrupting cell–matrix interactions and inducing selective, catastrophic oxidative stress in cancer cells, BthMP presents a dual-pronged anti-metastatic mechanism.
Conclusions
These findings establish BthMP as a promising therapeutic scaffold for developing novel treatments against lung cancer progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute Multidisciplinary in Health, Universidade Federal da Bahia (UFBA), Vitória da Conquista 45029-094, BA, Brazil.
- Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Universidade Federal de Uberlândia (UFU), Uberlândia 38405-318, MG, Brazil.
- Institute of Health Sciences, Universidade Federal da Bahia (UFBA), Salvador 40231-300, BA, Brazil.
- Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia (UFU), Uberlândia 38405-318, MG, Brazil.
- Laboratory of Immunopathology, Instituto Butantan, São Paulo 05585-000, SP, Brazil.
- Laboratory of Medical Investigation in Dermatology and Immunodeficiency, São Paulo Institute of Tropical Medicine, School of Medicine, Universidade de São Paulo (USP), São Paulo 05403-000, SP, Brazil.
ORCID-Profile: Vinícius Queiroz Oliveira, Lucas Miranda Marques, Amélia Cristina Mendes de Magalhães Gusmão, Thiago Macedo Lopes Correia, Eloisa Amália Vieira Ferro, Veridiana de Melo Rodrigues, Sarah Natalie Cirilo Gimenes, Mônica Colombini, Sabri Saeed Sanabani
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Fundação de Amparo à Pesquisa do Estado da Bahia
- National Council for Scientific and Technological Development
- Universidade Federal da Bahia (UFBA
- Universidade Federal de Uberlândia
- Instituto Butantan
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Oliveira, V. Q., Santos, L. C., Andrade, L. O. S. B., Marques, L. M., de Magalhães Gusmão, A. C. M., Correia, T. M. L., Teixeira, S. C., Ferro, E. A. V., de Melo Rodrigues, V., Gimenes, S. N. C., Colombini, M., Clissa, P. B., Sanabani, S. S., & Lopes, D. S. (2026). Selective Anticancer Effects of a P-I Metalloproteinase from Bothrops Moojeni Snake Venom (BthMP) on Lung Cancer Cells. Pharmaceuticals, 19(3), 428. https://doi.org/10.3390/ph19030428
Vancouver
Oliveira VQ, Santos LC, Andrade LOSB, Marques LM, de Magalhães Gusmão ACM, Correia TML, et al. Selective Anticancer Effects of a P-I Metalloproteinase from Bothrops Moojeni Snake Venom (BthMP) on Lung Cancer Cells. Pharmaceuticals. 2026;19(3):428. doi:10.3390/ph19030428
BibTeX
@article{Oliveira2026,
author = {Oliveira, Vinícius Queiroz and Santos, Luísa Carregosa and Andrade, Leonardo Oliveira Silva Bastos and Marques, Lucas Miranda and de Magalhães Gusmão, Amélia Cristina Mendes and Correia, Thiago Macedo Lopes and Teixeira, Samuel Cota and Ferro, Eloisa Amália Vieira and de Melo Rodrigues, Veridiana and Gimenes, Sarah Natalie Cirilo and Colombini, Mônica and Clissa, Patricia Bianca and Sanabani, Sabri Saeed and Lopes, Daiana Silva},
title = {Selective Anticancer Effects of a P-I Metalloproteinase from Bothrops Moojeni Snake Venom (BthMP) on Lung Cancer Cells},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {3},
pages = {428},
doi = {10.3390/ph19030428}
}
EUVIMED